The article compares structural brain changes and molecular signatures in Alzheimer’s disease and late-life depression, highlighting distinct patterns of gray matter loss and neurotransmitter systems. It also notes overlaps in serotonin disruption and mitochondrial energy issues, while pointing out condition-specific differences in cholinergic, dopaminergic, and glutamatergic dynamics.
The piece is of interest to psychology readers because it connects brain structure, chemical signaling, and cell-level differences to clinically observable symptoms, illustrating how distinct biological pathways can underlie similar cognitive and mood presentations.
Article Title: Scientists map the structural and chemical differences between Alzheimer’s disease and late-life depression
Link to PsyPost Article: https://nolinkpreview.com/www.psypost.org/scientists-map-the-structural-and-chemical-differences-between-alzheimers-disease-and-late-life-depression/
#Alzheimer's #LateLifeDepression #graymatter #neurotransmitters #serotonin #dopamine #glutamate #NMDA #PVALB #interneurons

A study co-authored by a Brown University computational cognitive neuroscientist showed how an SSRI improves cognitive flexibility, suggesting a new way of thinking about obsessive-compulsive disorder.
Why Your Gut Health Is Quietly Running Your Mood — And What To Do About It
For a long time I thought of my gut and my brain as separate systems that occasionally communicated in obvious ways — the nervous stomach before a difficult conversation, the loss of appetite when something went wrong, the way stress could make digestion uncomfortable. Those connections seemed self-evident and relatively minor. Background noise between two systems that otherwise operated independently. What I didn't know — and what I found genuinely shocking when I first encountered it […]This brief highlights a mechanistic link between serotonin signaling and tinnitus, a topic with direct relevance to mental health care. The work uses contemporary brain stimulation methods in animal models to map a serotonin-driven circuit associated with tinnitus-like behaviors, offering a potential framework for understanding how mood-related neurochemistry may interact with perceptual disturbances.
For clinicians across psychotherapy, social work, and allied mental health disciplines, the content informs ongoing consideration of how pharmacologic modulation of serotonin could interact with sensory experiences such as tinnitus, and it may prompt careful attention to patient-reported changes in tinnitus symptoms during treatment with SSRIs or similar agents.
Article Title: The brain’s “feel good” chemical may be secretly fueling tinnitus
Link to Science Daily Mind-Brain News: https://nolinkpreview.com/www.sciencedaily.com/releases/2026/05/260515002155.htm
#tinnitus #serotonin #neuroscience #mentalhealth #psychopharmacology #anxiety #depression #brainresearch #neuroplasticity #clinicalimplications
This brief highlights a development in psychopharmacology that directly relates to mood regulation and resilience, areas of ongoing clinical interest for mental health practitioners. The reported work describes psychedelic-like compounds that engage serotonin pathways linked to brain plasticity without eliciting full psychedelic effects in animal models, suggesting a potential path to novel depression treatments with fewer experiential risks. For therapists, the finding may inform future conversations about emerging pharmacotherapies and the mechanisms by which mood and plasticity are influenced.
Article Title: New psychedelic-like drugs could treat depression without making you trip
Link to Science Daily Mind-Brain News: https://nolinkpreview.com/www.sciencedaily.com/releases/2026/05/260512202325.htm
#mentalhealth #psychiatry #psychopharmacology #serotonin #brainplasticity #depressiontreatment #therapists #socialworkers #mentalhealthprofessionals #neuropharmacology